Clinical Trials
191
Active:2
Completed:100
Trial Phases
6 Phases
Early Phase 1:2
Phase 1:5
Phase 2:9
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (139 trials with phase data)• Click on a phase to view related trials
Not Applicable
80 (57.6%)Phase 4
34 (24.5%)Phase 2
9 (6.5%)Phase 3
9 (6.5%)Phase 1
5 (3.6%)Early Phase 1
2 (1.4%)Efficacy of a Photosynthetic Dermal Matrix for the Treatment of Full-Thickness Skin Wounds
Not Applicable
Recruiting
- Conditions
- Cronic Full-thinkness Skin WoundAcute Full-thickness Skin Wound
- Interventions
- Biological: Surgical implantation with standard (DRM) or photosynthetic dermal regeneration matrices (PDRM) in same patient.Procedure: Autologous split-thickness skin grafting over implanted matrices
- First Posted Date
- 2025-09-05
- Last Posted Date
- 2025-09-05
- Lead Sponsor
- Pontificia Universidad Catolica de Chile
- Target Recruit Count
- 20
- Registration Number
- NCT07157657
- Locations
- 🇨🇱
Hospital del Trabajador, Santiago, RM, Chile
Intraoperative Detection of Breast Cancer by Electrosurgical Gas Analysis and Artificial Intelligence
Recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2025-08-20
- Last Posted Date
- 2025-08-20
- Lead Sponsor
- Pontificia Universidad Catolica de Chile
- Target Recruit Count
- 30
- Registration Number
- NCT07131735
- Locations
- 🇨🇱
Facultad de medicina UC, Santiago, Región Metropolitana, Chile
🇨🇱Hospital Clínico UC CHRISTUS, Santiago, Santiago centro, Chile
Window Prophylaxis for Pediatric Tuberculosis Prevention Trial
Not Applicable
Not yet recruiting
- Conditions
- Tuberculosis InfectionHousehold ContactsChildrenAdolescentTuberculosis Infection, LatentTuberculosis
- Interventions
- Drug: Standard of care tuberculosis prophylaxis with weekly rifapentine and isoniazid for 12 weeksDrug: Tuberculosis window prophylaxis with weekly rifapentine and isoniazid for 12 weeks
- First Posted Date
- 2025-07-25
- Last Posted Date
- 2025-09-11
- Lead Sponsor
- Pontificia Universidad Catolica de Chile
- Target Recruit Count
- 647
- Registration Number
- NCT07086820
- Locations
- 🇨🇱
Hospital San Juan de Dios de La Serena, La Serena, Coquimbo Region, Chile
🇨🇱Hospital San Juan de Dios de Santiago, Santiago, Santiago Metropolitan, Chile
🇨🇱Hospital Dr. Carlos Cisterna, Calama, Antofagasta, Chile
The Developmental Origins of Obesity
Not Applicable
Recruiting
- Conditions
- Maternal ObesityObesity
- First Posted Date
- 2025-05-21
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Pontificia Universidad Catolica de Chile
- Target Recruit Count
- 160
- Registration Number
- NCT06981676
- Locations
- 🇨🇱
Red Salud UC Christus Hospital, Santiago, Metropolitana, Chile
CHAO Tos: Codeina, HederA Helix, LevOdropropizina Para la TOS
Phase 4
Recruiting
- Conditions
- Upper Resp Tract Infection
- Interventions
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- Pontificia Universidad Catolica de Chile
- Target Recruit Count
- 184
- Registration Number
- NCT06907355
- Locations
- 🇨🇱
Pontificia Universidad Catolica de Chile, Santiago, Chile
- Prev
- 1
- 2
- 3
- 4
- 5
- 39
- Next
News
No news found